Abstract

PurposeTo evaluate the ability of preoperative MRI-based radiomic features in predicting lymph node metastasis (LNM) in patients with cervical cancer. MethodsPubMed, Embase, Web of Science, Cochrane Library databases, and four Chinese databases were searched to identify relevant studies published up until October 22, 2021. Two reviewers screened all papers independently for eligibility. We included diagnostic accuracy studies that used radiomics-MRI for LNM in patients with cervical cancer, using histopathology as the reference standard.Quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies 2 and Radiomics Quality Score. Overall diagnostic odds ratio (DOR), sensitivity, specificity and area under the curve (AUC) were calculated to assess the prediction efficacy of MRI-based radiomic features in patients with cervical cancer. Spearman's correlation coefficient was calculated and subgroup analysis performed to investigate causes of heterogeneity. ResultsTwelve studies comprising 793 female patients were included. The pooled DOR, sensitivity, specificity, and AUC of radiomics in detecting LNM were 12.08 [confidence interval (CI) 8.18, 17.85], 80% (72%, 87%), 76% (72%, 80%), and 0.83 (0.76, 0.89), respectively. The meta-analysis showed significant heterogeneity among the included studies. No threshold effect was detected. Subgroup analysis showed that multiple sequences, and radiomics combined with clinical factors, radiomics approach [DOR:15.49 (6.06, 39.62), 18.93 (8.46, 42.38), and 10.63 (6.23, 18.12), respectively] could slightly improve diagnostic performance compared with apparent diffusion coefficient-based radiomic features, T2 + dynamic contrast-enhanced MRI-based radiomic features, T2 images-based radiomic features, single radiomics, and human reading [DOR: 4.9 (1.91, 12.74), 7.63 (3.78, 15.38), 8.31 (3.05, 22.61), 16.10 (9.10, 28.47), and 6.46 (3.08, 13.56), respectively]. ConclusionOur meta-analysis showed that preoperative MRI-based radiomic features performs well in predicting LNM in patients with cervical cancer. This noninvasive and convenient tool may be used to facilitate preoperative identification of LNM.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.